The new lung cancer staging system.
The International Association for the Study of Lung Cancer (IASLC) has conducted an extensive initiative to inform the revision of the lung cancer staging system. This involved development of an international database along with extensive analysis of a large population of patients and their prognoses. This article reviews the recommendations of the IASLC International Staging Committee for the definitions for the TNM descriptors and the stage grouping in the new non-small cell lung cancer staging system.
Detterbeck
Frank C
FC
Thoracic Surgery, Yale University School of Medicine, New Haven, CT. Electronic address: frank.detterbeck@yale.edu.
Boffa
Daniel J
DJ
Thoracic Surgery, Yale University School of Medicine, New Haven, CT.
Tanoue
Lynn T
LT
Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT.
D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology*; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology*; D009367:Neoplasm Staging / Q000379:methods*; D016019:Survival Analysis